Oral cancers with a high risk of recurrence can be identified at an early stage by examining the lymphatic vessels of the tumour. Finnish researchers...
Vous n'êtes pas connecté
Maroc - NEWS.MEDICAL.NET - A la Une - 17/01/2025 07:27
A recent study has made significant strides in uncovering how the oral microbiome, particularly the bacterium Fusobacterium nucleatum, plays a crucial role in the progression of oral squamous cell carcinoma (OSCC). By identifying key interactions between this common oral bacterium and host cells, the research has unveiled important metabolic pathways and mechanisms that may serve as potential therapeutic targets.
Oral cancers with a high risk of recurrence can be identified at an early stage by examining the lymphatic vessels of the tumour. Finnish researchers...
A recent integrative analysis of single-cell sequencing and single-cell spatial mapping of lymph node metastasis in breast cancer reveals novel...
Over the years, cell biology has built a detailed picture of how cells compartmentalize their internal functions. Central to this organization is the...
Nearly all cases of cervical cancer are caused by persistent infection with high-risk strains of Human Papillomavirus (HPV). “Nearly all cases of...
MONDAY, Feb. 23, 2026 -- Ultra-endurance running accelerates red blood cell (RBC) aging through inflammatory and oxidative pathways, according to a...
MONDAY, Feb. 23, 2026 -- Ultra-endurance running accelerates red blood cell (RBC) aging through inflammatory and oxidative pathways, according to a...
DelveInsight’s “Renal Cell Carcinoma Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+...
DelveInsight’s “Renal Cell Carcinoma Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+...
WEDNESDAY, March 4, 2026 -- For patients with stage T1a renal cell carcinoma (T1a RCC), ablation seems to be as effective as resection or...
THURSDAY, March 5, 2026 -- For patients with asthma, receipt of immune checkpoint inhibitor (ICI) therapy for melanoma or renal cell carcinoma is not...